A high quality breast cancer screening programme can be defined as one oVering both a high cancer detection rate and a low referral rate of women for further investigation. Such a programme will have as few women as possible undergoing further investigations who do not have a final diagnosis of breast cancer-that is, a high positive predictive value of referral for further investigation. This paper introduces a graphical technique to illustrate individual programme performance. The graph plots positive predictive value of referral against referral rate, with the cancer detection rate expressed as "isobars" on the graph. Confidence limits can be expressed as "boxes" on the diagram. The graph not only illustrates programme performance but also enables suggestions to be made to improve performance. The definition of high quality screening is seen to have a subjective element as well as an objective element, as radiologists have to balance screening sensitivity with specificity. The technique is illustrated using data from the individual screening programmes in the UK National Health Service Breast Screening Programme for the screening year 1 April 1998 to 31 March 1999. The methodology could also be applied to other national screening programmes. (J Med Screen 2001;8:24-28) 
The performance of the UK NHS Breast Screening Programme (NHSBSP) could be improved either by changes to the national protocol or by targeted improvements in the performance of individual programmes. Evaluation of individual screening programme performance is a diYcult process which requires careful analysis of annual return data, often over a number of years. An example of improvements by changes to the national protocol was the introduction in August 1995 of two view mammography for prevalent screens, following the results of a randomised controlled trial. 1 Further change is now proposed by implementing two view mammography across all screening programmes for incident as well as prevalent screens. Changes could also be made to the current recommendation of single reading, but without randomised controlled trials the precise improvement to screening eYciency from increasing the number of film readers is diYcult to estimate.
With a shortage of radiologists and other limitations on resources, an approach targeted at improving the performance of individual screening programmes at the lower end of the continuum of programme performance could be useful, thereby increasing the performance of the national programme as a whole. To some extent, this is already being carried out by the existing quality assurance process. However, performance, particularly for smaller programmes, is often diYcult to measure. The purpose of this paper is to introduce additional methodology to improve the evaluation of individual programme performance. This methodology is complementary to the current target measures such as cancer detection rates and interval cancer rates.
WHAT IS "HIGH QUALITY" IN BREAST CANCER SCREENING?
To define a "high quality" of screening we need to define the basic desirable characteristics of a screening programme. In breast cancer screening the theoretically perfect programme would deliver 100% sensitivity (that is, all breast cancer cases are correctly identified) together with 100% specificity (that is, all women without breast cancer are correctly identified). The positive predictive value (PPV) of referral of screening would be 100%-that is, all women referred for further investigation would have cancer. In practice, screening is a two stage process, with the first stage (mammography) identifying those likely or not likely to have the disease in question (breast cancer).
Mammography as a screening technique can never, even theoretically, achieve 100% sensitivity as some cancers are not detectable using this technique (mammographically occult). In addition, film reading and assessment are skill dependent and as such we would anticipate a continuum of performance.
We can suggest that a high quality programme be defined as a programme with: (a) high cancer (particularly invasive cancer) detection rate, (b) low referral rate, and (c) high PPV of referral, which is a consequence of the first two criteria. As with all screening tests there is a "trade oV" between detection rate and referral rate but in mammography radiologists must use their skill and judgement to determine whether a particular mammographic sign should or should not result in referral of the woman for further investigation. This is diVerent to a screening test such as PSA testing for prostate cancer where there is still a detection rate/ referral rate (sensitivity/specificity) trade oV but the test is not intrinsically "skill dependent". In the NHSBSP, which currently recommends single reading, individual radiological skill is supplemented in most programmes by double reading. This can be referral if either reader suggests, consensus, or arbitration by a third reader.
Methods

GRAPH OF PPV OF REFERRAL AGAINST REFERRAL
RATE WITH CANCER DETECTION RATE "ISOBARS" Graphically, there are six ways of expressing the three variables cancer detection rate, referral rate, and PPV. One way of showing individual programme "operating characteristics" is a graph of PPV of referral for all cancers on the y axis against referral rate on the x axis. The cancer detection rate can then be expressed as "isobars" of constant cancer detection rate on the graph. This way of presenting information focuses attention on the PPV and referral rate while also giving information on cancer detection rate.
PPV is defined as the number of cancers detected divided by the number of women referred for further investigation (for women aged 50-64 years), expressed as a percentage. The referral rate is defined as the number of women (aged 50-64 years) referred for further assessment divided by the number of women screened, expressed as a percentage. The cancer detection rate is then given by the PPV multiplied by the referral rate and is indicated by isobars, as illustrated in fig 1. Numerically, the three variables are related as: PPV (%)=10×cancer detection rate (per 1000)/ referral rate (%).
For a given cancer detection rate, the higher the quality of the programme, the further to the left on the curve the programme will be operating. For example, a programme with a cancer detection rate of 6 per 1000, referral rate of 3%, and PPV of 20% is clearly performing more eYcient screening than a programme with the same cancer detection rate but with a referral rate of 6% and PPV of only 10%. The background incidence of breast cancer in the catchment area is important as this will aVect the cancer detection rate. However, nearly all programmes in the NHSBSP have incidence rates within 10% of the England and Wales average. 2 The data presented in this paper are for one year only (the screening year 1998/99). Data have been combined from prevalent (first) and incident (subsequent) screens to provide a higher level of statistical stability. Confidence limits can be placed around the PPV and referral rate, which are graphically displayed as a box around the point estimate.
PPV-referral diagrams can be produced for invasive cancers only or for prevalent screens and incident screens separately, but data for many of the smaller individual programmes would need to be combined over several years to gain suYcient statistical stability. These two diagrams would then be compatible with current NHSBSP standards (see appendix 1).
To further examine individual programme performance and to complement the crude cancer detection rate, use has been made of the age standardised invasive cancer detection ratio expressed as the standardised detection ratio (SDR). The SDR is the ratio of the observed number of invasive cancers to the expected number of invasive cancers based on parity with the Swedish two county study. 3 4 The SDR can be corrected for variations in background incidence 2 and is a key target indicator of screening used by the NHSBSP.
Results
The PPV-referral diagram for the 95 individual screening programmes of the NHSBSP for 1998/99 is shown in fig 2. This diagram relates to women aged 50-64 years for prevalent and incident screens combined, and PPV is for all cancers. The range of referral rates is 1.9-9.2%, and the range of PPVs 5.6-25.9%, suggesting substantial variation in individual screening programme performance. Table 1 shows these data for all 95 programmes and for the 55 largest programmes screening at least 10 000 women each. The variation even for the larger programmes is still substantial and illustrates that these variations represent genuine diVerences in underlying screening programme performance rather than chance statistical variation from small programmes.
Three programmes have been chosen to illustrate the use of this methodology. It should be noted that none of these programmes is under performing with regard to invasive cancer detection rate, as measured by the SDR. Detailed information on these programmes is given in table 2. Programme A has a cancer detection rate of 6.59 per 1000 and an SDR of 1.26. PPV of referral is 18.0% and referral rate is 3.7%. The programme shows strong evidence of a very high quality of screening with a high cancer detection rate and a low referral rate. Figure 2 also shows the 90% confidence limits around the PPV and referral rate, shown on the PPV-referral diagram as a box or oblong as the referral rate is more statistically stable than PPV. For this programme the results can be seen to be reasonably robust even with only one year of data. The referral rate is more statistically stable than PPV, and very small programmes may need more than one year of data to obtain a reliable estimate of the underlying PPV.
Programme B has a cancer detection rate of 4.95 per 1000 with a corresponding SDR of 0.95. It has a very low referral rate of only 1.91% and a very high PPV of 25.9%. The film reading is by consensus, and the low referral rate suggests the film readers have adopted a very high index of suspicion before a woman is referred for assessment. The programme may therefore be under achieving with regard to detection of cancers but at the same time has relatively few women referred for further investigation who do not have cancer. A low SDR may lead to a lower mortality reduction, and the programme could probably increase its SDR with a small increase in referral rate.
Programme C has a cancer detection rate of 3.3 per 1000 and a corresponding SDR of 0.77. It has a referral rate of 5.89% and a PPV of only 5.61%. While above the target minimum SDR of 0.75, this programme has suggestive evidence of a poorer quality of screening compared with programmes A and B. Suggestions Referring more women will not drop the cancer detection rate, and with a referral rate of 4% with no extra cancers detected the programme operating characteristics will move to point Y. If the referral rate changed to 4% and PPV remained the same, the programme will be operating at point X. In practice, PPV will drop because the additional women referred will have a lower "index of suspicion". An increase in referral rate by this programme to 4% will most likely result in a much higher cancer detection rate, and the programme will have operating characteristics closer to programme A.
Discussion
The aim of this paper is to provide further techniques to enhance the monitoring and evaluation of screening in the NHSBSP. It allows programme performance to be examined in such a manner that each programme can readily compare their own performance with all other programmes. Constructive suggestions to improve performance can then be made (if necessary). Clearly, whether a programme has the correct sensitivity/specificity trade oV is a matter of debate, and it is entirely possible that the film readers are aware of their own preferences and limitations. Nevertheless, this new method of data presentation enables them to see their quality of screening in context with the other 95 programmes from the NHS-BSP in one simple diagram.
In the 1998/99 screening year, four programmes (table 3) were identified that had a referral rate which may be too low to achieve the highest levels of cancer detection. Clearly these programmes also have some of the lowest percentages of women undergoing unnecessary further investigations but possibly at the expense of low SDRs. Again, it should be emphasised that these programmes are not under performing by current NHSBSP minimum targets. The purpose of the PPV-referral diagram is to alert the radiologists to their own screening practices in comparison with other programmes.
A comparison of programmes A and B illustrates the dilemma that radiologists face when attempting to minimise the number of women undergoing unnecessary further investigations. Radiologists in programme B may be aiming to reduce recall rate but possibly at the expense of cancer detection. In practice, programme B could refer women with a lower "index of suspicion" than usual, and monitor this by examining referral rates over three monthly periods. If the women referred with an "index of suspicion" lower than in previous years could be identified, the number of cancers detected from the additional group of referred women could be examined at the end of the year. Some programmes may have adopted the opposite viewpoint and are referring very high percentages of women to obtain high detection rates. Are these programmes over referring women to achieve this detection rate? Could they improve screening quality by using more views and/or readers or additional training to obtain the same detection rate at a lower recall rate? Table 4 shows analysis of 1998/99 prevalent and incident screen data by reader/view protocol. These data confirm earlier observations 5 that the highest detection rates are achieved on average by those programmes using double reading with arbitration. These data support the conclusion that programmes with lower detection rates would be advised to use double reading with arbitration for a period and examine the results with this protocol. Despite the observation being based on only two screening programmes, it is of interest that those programmes using double reading with arbitration with two views show the highest quality of screening, with a combination of high detection rate, low referral rate, and high PPV.
Clearly there has to be a balance in terms of referral rate and cancer detection rate, and this to some extent is decided by the individual radiologist(s) at each screening programme. While the NHSBSP sets target criteria (for example, an SDR of at least 1, and a referral rate at prevalent screens of less than 7% and at incident screens of less than 5%) these are very broad operating criteria. At present the NHS-BSP does not set a guideline minimum percentage of women that should be referred but the PPV-referral diagram suggests that this could be useful. Clearly, there is a strong subjective element to screening, which is the concern of radiologists, quality assurance staV, and women attending for screening. The additional cancers which are likely to be detected by a programme (such as programme B) increasing its referral rate are likely to be those characterised as "minimal signs".
In conclusion, the simple technique presented in this paper enables radiologists to compare their screening performance with other programmes and determine the "quality" of screening being oVered at their programme compared with other programmes. It is recommended that smaller programmes examine three years of screening data together with the SDR for the three years, as one year's data may be insuYcient. Confidence limits will enable determination of whether one year's data is suYcient to determine programme quality. The SDR should be presented with and without background incidence correction factors to give a fuller picture of programme performance. The PPV-referral diagram is not intended as a proscriptive measure like a target, but rather as a technique which allows an investigation into the quality of screening at individual programmes which could lead to suggestions as to how individual programme performance could be improved.
Appendix 1
PPV-REFERRAL DIAGRAMS AND NHSBSP
STANDARDS
The PPV-referral diagram, as presented in the main body of the paper, does not relate directly to current NHSBSP standards. To use the diagram with current standards the prevalent and incident screen results for invasive cancers only, combined over a period of up to three years, should be considered to increase statistical stability for smaller programmes. Table A1 shows the relevant details. The PPV-referral diagram is then of the PPV for detection of invasive cancers against referral rate, with isobars constructed for the target and minimum rates. The return forms from individual screening programmes (known as KC62 returns) have information for prevalent screens in tables A and B on the KC62 returns (see tables A1, A2), and for incident screens in table C1 on the KC62 returns (see tables A1, A2). These tables refer to women who are attending their first invitation to screening (table A on the KC62 returns), attending their first invitation but are previous non-attenders (table B on the KC62 returns), or attending a routine invitation to screening having previously attended their last screen (table C1 on the KC62 returns).
Appendix 2
EXAMPLE PROGRAMME CALCULATIONS AND
CONFIDENCE LIMITS
The sample programme is illustrated in table A2.
CALCULATION OF CONFIDENCE LIMITS
A 90% confidence limit for a proportion can be calculated as p±1.645×sqrt(p(1−p)/n), where n is the denominator used to calculate the proportion. If 142 cancers are detected from 789 referred women, PPV is 0.1800 or 18.00%. The 90% confidence limits are given by 0.1800 ± 1.645 × sqrt (0.1800 (1−0.1800)/ 789) = 0.1800 ± 0.0225 = 0.1575−0.2025 or 15.75-20.25%. If 789 women are referred from 21 559 women, the referral rate is 3.66%. The 90% confidence limits are given by 0.0366 ± 1.645 × sqrt (0.0366 (1−0.0366)/ 21559) = 0.0366 ± 0.0021 = 0.0345−0.0387 or 3.45-3.87%. The 90% confidence limits can be expressed on the PPV-referral diagram as a "box", as shown in fig 2. Programme has an overall referral rate of 3.7%, cancer detection rate of 6.6 per 1000, and PPV of 18.0% (programme in section 7 on graph). SDR=1.26. PPV, positive predictive value; SDR, standardised detection ratio.
